MarketsandMarkets Presents
Breast Biopsy Market - Emerging Trends | Global Industry Future
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
The report Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), by Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020 , provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with estimates and forecast of revenue. Browse: 75 market data tables 66 figures 152 pages And in-depth TOC on ÍžBreast Biopsy MarketÍ&#x; Download The PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=189011805 The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
In this report, the global market is segmented on the basis of product, type, guidance, and regions.
Based on type, the market is categorized into needle breast biopsy (NBB) and open surgical breast biopsy (OSBB). The NBB is further subsegmented into core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB). Talk to Our Research Experts@ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=189011805
Among these, VAB is expected to be fastest-growing segment owing to the growing demand for less-invasive breast biopsy procedures worldwide. OSBB is further segmented into excisional and incisional breast biopsy.
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
Factors such as increased breast cancer screening programs in different countries, the rising incidence of breast cancer among women, increased reimbursement rates in the U.S. for image-guided biopsies, and the increasing demand for less-invasive breast biopsies are the key factors driving the growth of the breast biopsy market.
However, the risk of infection due to improper care of breast biopsy cuts and wounds and
uncertain regulatory approval procedures for medical devices are likely to restrain the growth of the market.
The market is segmented on the basis of product, type, guidance, and region. The breast biopsy guidance market is categorized into mammography, ultrasound, MRI, and others (PET and thermography).
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
In this market, the ultrasound segment is expected to be the fastest growing owing to the increasing demand for minimally invasive and non-radiation breast biopsy among patients and surgeons.
On the basis of type, the market is classified into needle and open surgical breast biopsy market. The needle breast biopsy segment is expected to account for the largest share of
the global breast biopsy market.
The large share of this segment can be attributed to the increased preference for needle
biopsies over open surgical breast biopsies and the demand for scar-less and painless surgical procedures.
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
On the basis of region, the breast biopsy market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America is expected to account for the largest share of the breast biopsy market, followed by Europe.
However, Asia-Pacific is expected to register a higher growth rate during the forecast period. The growth of the breast biopsy market in Asia-Pacific will be centered on China
and India.
Major players operating in the breast biopsy market are Becton, Dickinson and Company
(U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), and Hologic Inc. (U.S.).
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
About MarketsandMarkets™ Marketsa dMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co pa ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Marketsa dMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Marketsa dMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Marketsa dMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. Marketsa dMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. Marketsa dMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
Contact Us Mr. Rohan MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets